ArticleTranslational lung cancer research2021

Phase I study of afatinib plus bevacizumab in patients with advanced non-squamous non-small cell lung cancer harboring

Ryo Ko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.